About Baylor Scott & White Research Institute
Baylor Scott & White Research Institute (BSWRI) is the dedicated research and development arm of the largest not-for-profit healthcare system in Texas. BSWRI provides the critical infrastructure and operational resources needed to both safely and effectively conduct research across a broad range of specialty areas.
By the numbers:
- Empleando a más de 600 empleados, incluidos científicos, asistentes de laboratorio, enfermeros de investigación, asistentes de investigación clínica y coordinadores de investigación
- Utilizing more than 200,000-square-feet of research space
- Realizar más de 2,000 protocolos de investigación activos, abarcando más de 60 especialidades médicas
- Sirviendo a más de 800,000 personas en centros médicos en todo nuestro sistema de atención médica
- Publishing more than 500 peer reviewed publication
Our patients and community members are at the heart of everything we do at BSWRI
Un aspecto clave de brindar una atención de alta calidad y centrada en el paciente es garantizar que nuestra investigación también se centre realmente en el paciente. Desde el descubrimiento de nuevas terapias que mejoran las opciones de tratamiento disponibles hasta el estudio de la salud de la población y otras tendencias que mejoran la calidad de la atención, nos comprometemos a llevar la innovación a la vanguardia de la atención médica al hacer que los estudios de investigación y los ensayos sean más accesibles para las diversas comunidades a las que nuestro sistema sirve.
Publicadas con frecuencia en las principales revistas científicas e informadas en reuniones médicas y científicas, nuestra investigación ha dado como resultado más de 500 patentes pendientes que abarcan inmunoterapia, genómica, biomarcadores, metabolómica, enfermedades metabólicas, cardiovasculares y dispositivos médicos. BSWRI también posee carteras sólidas de investigación cardiovascular, oncológica y de trasplantes, además de supervisar estudios en casi 50 otras áreas especializadas.
Learn more about clinical research by following:
How you can participate in clinical research
Ofrecemos a los pacientes la oportunidad de participar en ensayos clínicos en una amplia gama de especialidades médicas. Al participar en un ensayo clínico, puede desempeñar un papel más activo en su propia atención médica y ayudar a otros contribuyendo a la investigación médica. El Baylor Scott & White Research Institute realiza ensayos clínicos en el norte de Texas y el centro de Texas.
To see if you qualify for enrollment in one of our clinical trials, call 1.844.BSW.DOCS (1.844.279.3627) or search online.
¿Por qué participar en un ensayo clínico?
Research is an important aspect in the fight against cancer. Cancer hates innovation—and research IS innovation. Participation in clinical trials helps create new ideas, and it helps researchers gain new knowledge, data, and insights that can impact potential treatments and medications that could help future generations. Taking part in research can also present patients who have attempted other treatments or are looking for other options with a choice not otherwise available to the general public because the medications and therapies involved are still being evaluated.
But research at Baylor Scott & White is about more than just seeing how we can treat cancer.
We have studies that seek to find better ways to detect and prevent cancer in patients who have never had it, may have a family history of it, or are worried about their cancer coming back. We also study how cancer progresses in different individuals and under different circumstances, such as when other health conditions are involved. And we have trials that seek to find ways to improve the quality of life for people who are living with cancer or who have just completed their treatment.
Participation in research can help inform every aspect of a patient’s cancer journey.
¿Cuáles son los riesgos potenciales?
Debido a que los ensayos clínicos y otros estudios de investigación están diseñados para evaluar un nuevo tratamiento o terapia, factores como la seguridad, los efectos secundarios y la efectividad básica son una parte natural de la evaluación. Como tal, los participantes pueden experimentar una respuesta adversa o correr el riesgo de que el tratamiento o la terapia no tengan ningún efecto. Todos estos factores se discuten con los pacientes antes de cualquier implicación, y los pacientes son monitoreados de cerca durante todo el proceso para detectar tales signos.
¿Tengo la garantía de obtener un medicamento o un placebo?
No todos los ensayos implican el uso de un placebo. Si el ensayo que está considerando involucra placebos, un miembro del equipo de investigación discutirá esta información y los detalles relacionados con usted antes de como parte de su evaluación inicial.
¿Qué tengo que hacer para calificar?
Every research opportunity has specific inclusion and exclusion criteria that help determine if a person qualifies for the study. Research team members review these criteria with interested participants as part of an initial screening. Criteria can include general information like your age, as well as more detailed factors, such as the stage of cancer you have or other health conditions or procedures in your medical history.
¿Cuáles son los costos involucrados en un ensayo clínico?
Every trial is different, but generally participants do not have to pay for costs tied to the treatments or medications involved in the trial. These costs are generally covered by the trial’s sponsor(s). The patient (or the patient’s insurance provider) maintains the responsibility of covering costs related to any routine testing, procedures or medications they take as part of their existing cancer treatment.
As part of the trial, a BSWRI team member will review study consent forms with you and provide information about what payments you are and are not responsible for making.
Research participation can require more appointments, lab work, in-person visits, or even hospital stays than a participant is used to having. This is needed as part of the monitoring and study process, but may require more time investments than expected. Appointment and other study-related details will be discussed in advance with participants as part of the enrollment process.
Una vez que me uno a una prueba, ¿debo seguir inscrito?
No, puede dejar de participar en un ensayo clínico en cualquier momento y por cualquier motivo. No está obligado a permanecer inscrito bajo ninguna circunstancia.
¿Cuáles son las diferentes fases de la investigación?
There are different types of studies and trials involved in research. Some focus on data collection and observation, or studying tissue and tumor samples. These types of studies generally require less time from the patient after samples and related information are initially captured. Others studies involve more direct patient interaction and monitoring – these are often the studies that involve evaluation of a new drug, or combination of drugs, or a new therapy or treatment approach. Below is a breakdown of these phases as explained by the U.S. Food and Drug Administration (FDA):
Phase 1: Studies that are usually conducted with healthy volunteers and that emphasize safety. The goal is to find out what the drug's most frequent and serious adverse events are and, often, how the drug is metabolized and excreted.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition). For example, participants receiving the drug may be compared with similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing. These including post-market requirement and commitment studies that are required of or agreed to by the sponsor. These studies gather additional information about a drug's safety, efficacy, or optimal use.
Baylor Scott & White Research Institute currently supports research within each of the different phases and categories mentioned above.
The All of Us Research Program is a large research program. The goal is to help researchers understand more about why people get sick or stay healthy. People who join will give us information about their health, habits, and what it’s like where they live. By looking at patterns, researchers may learn more about what affects people’s health. Baylor Scott & White Health is a proud participant of the All of Us Research Program, from the National Institute of Health.About the All of Us Research Program
Baylor Scott & White Research Institute (BSWRI) conducts research exploring different cancer medications, therapies and care options. We support a wide variety of trials, across all phases, related multiple types of cancer.About cancer research
Center for Applied Health Research (CAHR) is a collaborative, multidisciplinary system level research center within the Baylor Scott & White Research Institute. CAHR supports investigator-initiated research to generate applied health knowledge across our healthcare system.About CAHR
The Center for Esophageal Disease at Baylor University Medical Center features gastroenterologists, interventional endoscopists, laryngologists, esophageal surgeons and thoracic surgeons on the Baylor University Medical Center medical staff who have focused expertise in diagnosing and treating disorders of the esophagus.About esophageal research
Baylor Scott & White Research Institute (BSWRI) oversees a robust portfolio of cardiovascular trials and studies that has resulted in more than 500 issued and pending patents spanning cardiovascular disease and medical devices.About heart and vascular research
We focus our research on patients across our entire rehabilitation network. With a diverse patient group from acute care therapy, inpatient rehabilitation, outpatient therapy and our home health division, we are able to create unique research opportunities.About rehab research
We’ve performed many human organ transplant firsts in the state, nation and the world. We are globally recognized for our contributions to transplantation research and our effectiveness at translating complex studies to patients in need.About transplant research
Four babies have been born at Baylor University Medical Center, part of Baylor Scott & White Health to mothers who received a uterus transplant. These live births are the latest medical milestones in the uterine transplant clinical trial at Baylor University Medical Center in Dallas.About uterus transplant research
Our team is dedicated to producing high quality research aimed at improving care for warriors from a variety of fields.Warriors Research Institute
From our blogs and newsroom
Media Newsroom is the repository for all important news updates from Baylor Scott & White Health.
Scrubbing In® is a place where hands-on healthcare discussions are happening every day with the people whose own hands are on the front lines of patient care—the doctors, nurses and medical staff who are saving lives and advancing medicine at Baylor Scott & White Health.
BSWHealth.med blog is home to articles and commentary from physicians and other researchers at Baylor Scott & White Research Institute. Here you can read more about our latest research efforts and published works.
Baylor Scott & White Health Enrolls First Patients in the World in Trial for Inhaled Remdesivir
Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead's new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262).
Researchers launch new study to understand how face masks impact exercise
As research continues to advance our collective knowledge around care and treatment options for COVID-19, Baylor Scott & White Research Institute (BSWRI) is also opening avenues of research aimed at helping people adapt their everyday activities to the “the new normal” of today’s COVID-19 environment.
Can we slow COVID-19 progression? New trial explores
As researchers continue to explore treatment options for patients hospitalized with COVID-19, trials for individuals with mild enough symptoms to not need hospitalization have also moved toward activation in recent months.
Baylor Scott & White Research Institute enrolls first patients in new COVID-19 global clinical trial
Just one day after the initiative was launched by the National Institutes of Health (NIH), Baylor Scott & White Research Institute enrolled the first patient in the world for the ACTIV-3 clinical trial. A second patient was enrolled the following day.
Baylor Scott & White Research Institute Expands Efforts in the Fight Against COVID-19
As the global response to the SARS-COV-2 virus that causes COVID-19 approaches 200 days, Baylor Scott & White Research Institute, the research and development arm of Baylor Scott & White Health, is accelerating its pace of bringing clinical trials online.
Antibodies: What are they and how are they used in COVID-19 research and treatment?
Early on in the COVID-19 pandemic, the term “antibodies” was tucked into the various conversations about vaccines and treatment options that swirled through public and scientific communities alike. Could they help treat the sick? When could they be retrieved from recovered COVID-19 patients? How should they be administered?
NIH Awards Baylor Scott & White Research Institute RO1 Grant for Surgical Simulator Study
Baylor Scott & White Research Institute has received funding for a study from the National Institute of Biomedical Imaging and Bioengineering, one of the 27 institutes and centers of the National Institutes of Health (NIH).
Baylor Scott & White Researchers Receive $1.5 Million in NIH Funding to Study the Molecular Basis of Esophageal Cancer
The incidence of esophageal adenocarcinoma has increased 8-fold over the past 50 years.
Caring for frontline healthcare workers in times of crisis
COVID-19 has put clinical research under a global spotlight as we all look for answers to this pandemic that has uprooted our lives. The research community is putting a full-court press on this pandemic and those efforts have understandably captured public attention.
Un nuevo estudio de investigación tiene como objetivo descubrir el impacto emocional de COVID- 19
It’s difficult to put into words the changes that our world has seen in just a few short weeks. Not only are we confronted by the ever-present risk of illness by this invisible enemy, COVID-19, but there are so many creature comforts and “norms” that are no longer accessible in times of need.
Baylor Scott & White Research Institute Exploring Potential Prevention Options, Therapies for COVID-19
Baylor Scott & White Research Institute, the research arm of Baylor Scott & White Health, is bringing clinical trials online at an unprecedented pace in response to COVID-19.